Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,445,396
-
Share change
-
+69,862
-
Total reported value
-
$65,721,141
-
Price per share
-
$4.55
-
Number of holders
-
85
-
Value change
-
-$9,456,333
-
Number of buys
-
47
-
Number of sells
-
51
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q2 2020
As of 30 Jun 2020,
RECRO PHARMA INC - COM (SCTL) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,445,396 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Rubric Capital Management LP, MAK CAPITAL ONE LLC, D. E. Shaw & Co., Inc., Assenagon Asset Management S.A., PENN CAPITAL MANAGEMENT CO INC, STATE STREET CORP, and TWO SIGMA ADVISERS, LP.
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.